Jim Knaub, Premier Wheelchair Racer, Dies at 68
He motivated and challenged fellow paraplegics: ‘Why walk when you can fly?’
He motivated and challenged fellow paraplegics: ‘Why walk when you can fly?’
McDonald’s said Monday that it is scrapping set diversity targets for its employees and suppliers, the latest large company to overhaul its strategies for diversity,…
Papillary fibroelastomas (PFEs) are now believed to be the most common benign primary cardiac tumors, with increasing incidence due to improved detection by echocardiography.1 They…
The ACC is pleased to announce the recipients of its 2025 Distinguished Awards. This year’s honorees represent an inspiring group of individuals who hav e…
Michael Reardon, MD, co-principal investigator of the ACURATE IDE trial, discussed updated data on what may have impacted that study’s findings.
January 6, 2025—Stryker announced a definitive agreement to acquire Inari Medical, Inc. for approximately $4.9 billion. Inari was founded in 201
In dialysis-dependent patients, those on denosumab for fracture risk had a 36% higher MACE rate than those on bisphosphonates.
Find the answers to your proposal submission questions, plus links to the best resources for building a strong research application. Proposal deadline: Thurs., Jan. 30,…
The Times speaks with our CEO Thomas Oxley: Read the article by Rhys Blakely: https://lnkd.in/eSX-h4Qv
The ACC is pleased to announce the recipients of its 2025 Distinguished Awards. This year’s honorees represent an inspiring group of individuals who hav e…